# Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-trial-of-bevacizumab-in-recurrent-or-persistent-endometrial-cancer-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Carol Aghajanian,Michael W. Sill,Kathleen M. Darcy,Benjamin E. Greer,D. Scott McMeekin,Peter G. Rose,Jacob Rotmensch,Mack N. Barnes,Parviz Hanjani,Kimberly K. Leslie |
| Citations | 323 |
| DOI | 10.1200/jco.2010.32.6397 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.32.6397?role=tab |
| OpenAlex ID | https://openalex.org/W2154516141 |
| PMID | 21537039 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Carol Aghajanian](https://scholariq.org/researchers/carol-aghajanian/)
- [Peter G. Rose](https://scholariq.org/researchers/peter-g-rose/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)

## Paper topics

- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Gynecological conditions and treatments](https://scholariq.org/topics/gynecological-conditions-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.